ELEX Biotech - Crunchbase Company Profile & Funding

Q: Who invested in ELEX Biotech?

ELEX Biotech is funded by National Institutes of Health.

Q: When was the last funding round for ELEX Biotech?

ELEX Biotech closed its last funding round on obfuscated from a Grant round.

Q: How much funding has ELEX Biotech raised to date?

ELEX Biotech has raised obfuscated.

Overview

ELEX Biotech

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About ELEX Biotech

CB Rank

298561

Elex biotech develops drugs for the treatment of cardiovascular diseases.

Founded

obfuscation

Private

Grant

Kampenhout, Vlaams-Brabant, Belgium

1-10

www.elexbiotech.com

Biotechnology

Health Care

Life Science

Funding Rounds

Grant

OBF

obfuscation

Key People

Sandra Shotwell: Co-Founder
Past Role: DesignMedix, CEO, Founder & COO
Xander Wehrens: Co-Founder

Details

Legal Name

ELEX Biotech LLC

Operating Status

Active

Company Type

For Profit

Founders

Doug Kawahara, Guy Salama, Jonathan Abramson, Sandra Shotwell, Xander Wehrens

About the Company

ELEX Biotech develops small-molecule pharmaceutical drugs for the management and cure of cardiovascular diseases such as heart failure and arrhythmias, enabling physicians to offer effective treatments for heart-related diseases. These compounds modulate the function of calcium channels that control the contraction of cardiac muscle.

Phone Number

+1 503-488-5870

Diversity Spotlight

Women Founded

Predictions & Insights

Products & Services

RyR2 Channel Stabilizing Drug Candidates

Drug candidates designed to selectively target and stabilize the RyR2 calcium release channel to restore normal heart rhythm and treat arrhythmias.

Drug Discovery and Development Services for Cardiac Arrhythmias

Comprehensive drug discovery and development services targeting molecular mechanisms of arrhythmias, including lead identification, optimization, preclinical and clinical development.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - ELEX Biotech	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - ELEX Biotech	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - ELEX Biotech	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - ELEX Biotech	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - ELEX Biotech	1	obfuscated obfuscation	National Institutes of Health	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - ELEX Biotech	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - ELEX Biotech	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - ELEX Biotech	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - ELEX Biotech	1	obfuscated obfuscation	National Institutes of Health	Grant
obfuscated obfuscation	Grant - ELEX Biotech	1	obfuscated obfuscation	National Institutes of Health	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
National Institutes of Health	Yes	Grant - ELEX Biotech	—
National Institutes of Health	Yes	Grant - ELEX Biotech	—
National Institutes of Health	Yes	Grant - ELEX Biotech	—
National Institutes of Health	Yes	Grant - ELEX Biotech	—
National Institutes of Health	Yes	Grant - ELEX Biotech	—